Form 8-K - Current report:
SEC Accession No. 0001193125-24-239630
Filing Date
2024-10-18
Accepted
2024-10-18 16:06:59
Documents
13
Period of Report
2024-10-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d909780d8k.htm   iXBRL 8-K 27616
  Complete submission text file 0001193125-24-239630.txt   149367

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA zyme-20241015.xsd EX-101.SCH 2858
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE zyme-20241015_lab.xml EX-101.LAB 17996
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zyme-20241015_pre.xml EX-101.PRE 11267
15 EXTRACTED XBRL INSTANCE DOCUMENT d909780d8k_htm.xml XML 3629
Mailing Address 108 PATRIOT DRIVE, SUITE A MIDDLETOWN DE 19709
Business Address 108 PATRIOT DRIVE, SUITE A MIDDLETOWN DE 19709 302-274-8744
Zymeworks Inc. (Filer) CIK: 0001937653 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41535 | Film No.: 241380810
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)